MedPath

A clinical trial to study the effect of 2 formulations, mukha kantikara gel prepared by powder and its extract in patient with hyperpigmentatio

Phase 2
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2022/11/047667
Lead Sponsor
govt ayurvedic medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients with clinical signs of vyanga as per ayurvedic classics will be included.

chronicity less than 5 years.

Exclusion Criteria

inflammatory pigmentation

hyperpigmentation caused by tumor like malignant melanoma.

hyperpigmentation caused by acne vulgaris.

hyperpigmentation caused due to systemic diseases.

hyperpigmentation since birth.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvment in MASI scaleTimepoint: follow up on 45th day
Secondary Outcome Measures
NameTimeMethod
improvent in pigmentationTimepoint: on 45th day
© Copyright 2025. All Rights Reserved by MedPath